[numberonepal]

Vaxicide
ONE HUNDRED SEVENTY PEOPLE CHANGED THE WORLD

@dchomecoming 🚩 Out of 44,000 participants in Pfizer’s clinical trials, the mRNA doses were approved based on 170 participants. Of that 170—162 received the placebo and 8 participants received 2 doses of the mRNA. That’s how Pfizer claims to have reached 95% efficacy.
Receipts from Pfizer:

[stylin19a]

Thanx for that.

Moderna's Phase III trial that cemented its EUA on 12/20/2020 "The primary endpoint of the Phase 3 COVE study is based on the analysis of COVID-19 cases confirmed and adjudicated starting two weeks following the second dose of vaccine.

Vaccine efficacy has been demonstrated at the first /interim analysis with a total of 95 cases based on the pre-specified success criterion on efficacy.(my note: 90 were in placebo, only 5 got the shot - no women - this got them EUA consideration) https://investors.modernatx.com/news/news-details/2020/Modernas-COVID-19-Vaccine-Candidate-Meets-its-Primary-Efficacy-Endpoint-in-the-First-Interim-Analysis-of-the-Phase-3-COVE-Study/default.aspx

Today's primary analysis was based on 196 cases, of which 185 cases of COVID-19 were observed in the placebo group versus 11 cases observed in the mRNA-1273 group, resulting in a point estimate of vaccine efficacy of 94.1%.

A secondary endpoint analyzed severe cases of COVID-19 and included 30 severe cases (as defined in the study protocol) in this analysis. All 30 cases occurred in the placebo group and none in the mRNA-1273 vaccinated group. There was one COVID-19-related death in the study to date, which occurred in the placebo group."

https://investors.modernatx.com/news/news-details/2020/Moderna-Announces-Primary-Efficacy-Analysis-in-Phase-3-COVE-Study-for-Its-COVID-19-Vaccine-Candidate-and-Filing-Today-with-U.S.-FDA-for-Emergency-Use-Authorization/default.aspx

U.S. citizens were the real guinea pigs Phase III study.